| Subsets of ILC3− ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues M Cella, R Gamini, C Sécca, PL Collins, S Zhao, V Peng, ML Robinette, ... Nature immunology 20 (8), 980-991, 2019 | 194 | 2019 |
| Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2 JL Fachi, C Sécca, PB Rodrigues, FCP Mato, B Di Luccia, JS Felipe, ... Journal of Experimental Medicine 217 (3), 2020 | 180 | 2020 |
| ILC2s are the predominant source of intestinal ILC-derived IL-10 JK Bando, S Gilfillan, B Di Luccia, JL Fachi, C Sécca, M Cella, M Colonna Journal of Experimental Medicine 217 (2), e20191520, 2019 | 113 | 2019 |
| Circadian rhythm–dependent and circadian rhythm–independent impacts of the molecular clock on type 3 innate lymphoid cells Q Wang, ML Robinette, C Billon, PL Collins, JK Bando, JL Fachi, C Sécca, ... Science immunology 4 (40), eaay7501, 2019 | 84 | 2019 |
| IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering C Sécca, DV Faget, SC Hanschke, MS Carneiro, MH Bonamino, ... Journal of Leucocyte Biology 100 (5), 1081-1091, 2016 | 30 | 2016 |
| NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes LK Teixeira, N Carrossini, C Sécca, JE Kroll, DC DaCunha, DV Faget, ... Cell cycle 15 (17), 2346-2359, 2016 | 28 | 2016 |
| Differential interferon-γ production by naive and memory-like CD8 T cells PS de Araújo-Souza, SCH Hanschke, AFFR Nardy, C Sécca, ... Journal of Leucocyte Biology 108 (4), 1329-1337, 2020 | 19 | 2020 |
| Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity C Sécca, JK Bando, JL Fachi, S Gilfillan, V Peng, B Di Luccia, M Cella, ... Proceedings of the National Academy of Sciences 118 (23), e2101668118, 2021 | 15 | 2021 |
| TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy B Di Luccia, M Molgora, D Khantakova, N Jaeger, HW Chang, ... Science immunology 9 (95), eadi5374, 2024 | 5 | 2024 |
| Lack of TREM2 during anti-PD1 therapy reprograms intestinal macrophages and microbiota to enhance tumor rejection M Molgora, B Di Luccia, D Khantakova, N Jaeger, HW Chang, ... EUROPEAN JOURNAL OF IMMUNOLOGY 54, 474-474, 2024 | | 2024 |
| TREM2+ macrophages mediate immunosuppression in tumors M Molgora, BD Luccia, D Khantakova, N Jaeger, RS Czepielewski, ... Cancer Research 82 (12_Supplement), 3615-3615, 2022 | | 2022 |
| The transcriptional cofactor IRF2BP2 plays a key role in T cell homeostasis and Treg cell expansion GP Mognol, B Oliveira-Vieira, N Pinheiro-Rosa, BC Peixoto, M Boroni, ... bioRxiv, 2021.07. 29.454283, 2021 | | 2021 |
| Aiolos and T-bet cooperate to repress the ILC3 transcriptional program in human innate lymphocytes CS da Silva, M Cella, R Gamini, P Collins, S Zhao, V Peng, M Robinette, ... The Journal of Immunology 204 (1_Supplement), 84.9-84.9, 2020 | | 2020 |
| Differential interferon-𝜸 production by naive and memory-like CD8 T cells PSA Souza, SCH Hanschke, AFFR Nardy, C Sécca, BLMO Vieira, ... | | 2020 |
| Characterization of the involvement of transcriptional repressor IRF2BP2 on T-cell proliferative response BLMO Vieira, CS Secca, G Mognol, A Rao, JPB Viola CLINICAL CANCER RESEARCH 24 (1), 65-65, 2018 | | 2018 |
| Abstract A87: Characterization of the involvement of transcriptional repressor IRF2BP2 on T-cell proliferative response BLMO Vieira, CS Secca, G Mognol, A Rao, JPB Viola Clinical Cancer Research 24 (1_Supplement), A87-A87, 2018 | | 2018 |
| Avaliação da participação da proteína IRF2BP2 na ativação e diferenciação de linfócitos T CD4 CS Silva | | 2013 |
| Casalegno, Federico Casper, Brent Cassel, Gustavo Castedo, Luis A Cataliotti, M Catelani, S Catunda, Y Cekic, A Cervieri, C Chan, A Chan, ... | | |
